Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

Massachusetts Recap: Updates From the Fee Schedule Stakeholder Input Session

Fee schedule rates haven’t changed since 2009, and the low rates have discouraged provider participation.
Read More →
October 20, 2025

Texas Accepting Public Comments on Proposed Billing and Processing Rule Repeals

Written comments will be accepted via email until November 10th.
Read More →
October 20, 2025

California Enacts Bill to Expedite Research for Schedule I And Schedule II Drugs

Certain members of the Research Advisory Panel of California may conduct expedited reviews and approvals of research applications.
Read More →
October 20, 2025

WCRI Publishes 2025 Medical Benchmarks

Using data representing 60% of workers’ comp benefits nationwide, these reports examine trends in payments, prices, and utilization.
Read More →
October 20, 2025

Educational Webinar: The Impact of California’s Heat Standard on Workers’ Comp

The 30-minute webinar will take place October 30th at 2:00 PM ET, highlighting findings from their recent report.
Read More →
October 20, 2025

California Expands Cancer, PTSD, and Cardiovascular Presumptions

Two recently enacted bills expand pre-existing presumptions to additional workers.
Read More →
October 13, 2025

Oregon and Washington Issue Guidance for Sign Language Interpreter Services

Considering recent and upcoming changes to the procurement of these services, both states have published bulletins to clarify procedures.
Read More →
October 13, 2025

Cannabis Drug Beats Opioid in Phase 3 Clinical Trial for Low Back Pain

A lack of clinical research has been a barrier for the greater utilization of medical marijuana, but one cannabis-derived drug shows promise.
Read More →
October 13, 2025

Quest Diagnostics Publishes 2025 Drug Testing Index

Positivity rates for fentanyl in random drug checks were 707% higher when compared to pre-employment drug tests.
Read More →
October 13, 2025
1 2 3 4 … 36

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Cybersecurity Strategies to Balance Innovation & Caution in the Age of AI

Healthesystems AVP of Information & Technology Security, Tony Brown, will speak about this topic at the 2025 IAIABC Convention.
Read More

Tracking Sub-Regulatory Changes in Workers’ Comp

Healthe’s VP of Industry and State Affairs, Sandy Shtab, shares her thoughts with Risk & Insurance magazine in a recent article.
Read More

FDA Orders Opioid Manufacturers to Update Prescribing Information for Long-Term Use

All opioid manufacturers must update their drug labeling to align with a list of notes provided by the FDA.
Read More

Burden of Proof: Unpacking Presumptions in Workers’ Comp

Exploring the expansion of presumptions in PTSD, cancers, and more.
Read More

FDA Takes Steps to Restrict Certain Kratom Products

The FDA recommended concentrated 7-OH kratom products to be rescheduled under the Controlled Substances Act.
Read More

The Emerging Role of AI in Workers’ Comp – and the Regulations Surrounding It

An expert Q&A with Sandy Shtab, VP of Industry and State Affairs, on AI in workers’ comp and the regulations surrounding it.
Read More
1 2 3 4 … 46
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle